Raymond James Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-736
| Closed | -$264K | – | 1212 |
|
|
2023
Q3 | $264K | Sell |
736
-24
| -3% | -$8.6K | 0.01% | 932 |
|
|
2023
Q2 | $288K | Buy |
760
+59
| +8% | +$22.4K | 0.01% | 910 |
|
|
2023
Q1 | $336K | Buy |
+701
| New | +$336K | 0.01% | 815 |
|
|
2022
Q4 | – | Sell |
-616
| Closed | -$257K | – | 1135 |
|
|
2022
Q3 | $257K | Buy |
616
+115
| +23% | +$48K | 0.01% | 857 |
|
|
2022
Q2 | $248K | Hold |
501
| – | – | 0.01% | 906 |
|
|
2022
Q1 | $283K | Buy |
501
+26
| +5% | +$14.7K | 0.01% | 910 |
|
|
2021
Q4 | $359K | Buy |
475
+47
| +11% | +$35.5K | 0.01% | 794 |
|
|
2021
Q3 | $319K | Sell |
428
-17
| -4% | -$12.7K | 0.01% | 823 |
|
|
2021
Q2 | $286K | Sell |
445
-28
| -6% | -$18K | 0.01% | 873 |
|
|
2021
Q1 | $270K | Buy |
+473
| New | +$270K | 0.01% | 874 |
|
|
2018
Q4 | – | Sell |
-771
| Closed | -$241K | – | 826 |
|
|
2018
Q3 | $241K | Buy |
771
+36
| +5% | +$11.3K | 0.01% | 730 |
|
|
2018
Q2 | $212K | Buy |
+735
| New | +$212K | 0.01% | 759 |
|